Risk of Thrombosis during and after COVID Infection

By Wael Mahmoud Aboulthana and Noha El-Sayed Ibrahim

The novel coronavirus known as SARS-CoV-2 is a respiratory virus that presents with symptoms such as a non-productive cough (60-80%), fever (90%) and shortness of breath (19-40%) and is responsible for the 2019-2020 global coronavirus disease (COVID-19) pandemic. Although most patients experience mild or no symptoms, severe disease is associated with thromboembolic complications and respiratory failure. There is an observed rise in the clinical manifestations of the disease 7 to 14 days after initial symptom onset and also associated with thrombotic complications. Understanding the thrombotic manifestations of the virus is important for patient management.

• Format: Paperback
• Language: English
• ISBN: 613894691X
• ISBN13: 9786138946915
• Release Date: July 2025
• Publisher: Scholars' Press
• Length: 56 Pages
• Weight: 0.19 lbs.
• Dimensions: 0.1" x 6.0" x 9.0"